These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey. McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000 [TBL] [Abstract][Full Text] [Related]
9. ICD: a qualitative study of patient experience the first year after implantation. Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: identification of foci for nursing intervention. Wong FM; Sit JW; Wong EM; Choi KC J Adv Nurs; 2014 Dec; 70(12):2821-34. PubMed ID: 24754723 [TBL] [Abstract][Full Text] [Related]
11. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279 [TBL] [Abstract][Full Text] [Related]
12. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy. Meissner MD; Lehmann MH; Steinman RT; Mosteller RD; Akhtar M; Calkins H; Cannom DS; Epstein AE; Fogoros RN; Liem LB J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649 [TBL] [Abstract][Full Text] [Related]
13. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator: present and future indications. Block M; Scheld H; Breithardt G Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176 [TBL] [Abstract][Full Text] [Related]
15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
16. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study. Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972 [TBL] [Abstract][Full Text] [Related]
17. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial. Versteeg H; Timmermans I; Widdershoven J; Kimman GJ; Prevot S; Rauwolf T; Scholten MF; Zitron E; Mabo P; Denollet J; Pedersen SS; Meine M Europace; 2019 Sep; 21(9):1360-1368. PubMed ID: 31168604 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients. Cinar FI; Tosun N; Kose S J Clin Nurs; 2013 Sep; 22(17-18):2474-86. PubMed ID: 23551749 [TBL] [Abstract][Full Text] [Related]
19. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey. Januszkiewicz Ł; Barra S; Providencia R; Conte G; de Asmundis C; Chun JKR; Farkowski MM; Guerra JM; Marijon E; Boveda S Europace; 2022 May; 24(5):860-867. PubMed ID: 35167672 [TBL] [Abstract][Full Text] [Related]
20. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Herman D; Stros P; Curila K; Kebza V; Osmancik P Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]